Pursuing Global Equity in Access to Cancer Drugs

This Viewpoint suggests a strategy to provide breakthrough cancer drugs to patients in lower-income countries for much lower costs while not disincentivizing pharmaceutical innovation.

Read the full article here

Related Articles